Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL
Armistice Capital, LLC reported a 8.95% stake in Rigel Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Armistice Capital, LLC reported a 8.95% stake in Rigel Pharmaceuticals, Inc., 1,672,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 8.95%
- Shares
- 1,672,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 8.95% | 1,672,000 |
| Steven Boyd | 8.95% | 1,672,000 |
Source
Related
- Rigel Pharmaceuticals, Inc.
- Armistice Capital, LLC
- Rigel Pharmaceuticals, Inc. shareholders
- Schedule 13G · Armistice Capital, LLC · May 15, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Schedule 13G/A · Armistice Capital, LLC · Feb 14, 2025
- Form 4 · Schorno Dean L · Sep 3, 2026
- Form 4 · Santos David A · Sep 3, 2026
- Form 4 · Rodriguez Raul R · Sep 3, 2026
- Form 4 · Furey Raymond J. · Sep 3, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · Aug 13, 2026